A common energy drink ingredient has been linked to the progression of the blood cancer leukemia, prompting researchers to voice concerns about the consumption of those beverages, People’s Cara Lynn Shultz reports. Taurine – an amino acid that occurs naturally in proteins like meat and fish – is a common ingredient in energy drinks like Red Bull. As the Mayo Clinic explains it can help balance fluids, salts and minerals. But according to research published in Nature, taurine may promote leukaemogenesis – the development of leukemia cells – and “identifies taurine as a key regulator of myeloid malignancies,” which, like leukemia, are cancers that begin in the blood, the author notes. Publicly traded companies in the space include Monster Beverage (MNST) and Celsius (CELH).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNST:
- Monster Beverage price target raised to $56 from $50 at Roth Capital
- Monster Beverage upgraded to Outperform from Market Perform at CICC
- Monster Beverage’s Earnings Call: Growth Amid Challenges
- Monster Beverage: Hold Rating Amid Mixed Performance and Valuation Concerns
- Monster Beverage: Hold Rating Amid Mixed Performance and Market Uncertainties
